UB Paderborn / Katalog / Suche / in CDI

Novel (2E,4E,6Z)-7-(2-Alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic Acid Retinoid X Receptor Modulators Are Active in Models of Type 2 Diabetes

Journal of medicinal chemistry, 2003-06, Vol.46 (13), p.2683-2696

2003

Volltextzugriff (PDF)

Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone

The Journal of biological chemistry, 1997-03, Vol.272 (10), p.6539-6547

1997

Volltextzugriff (PDF)

Conformationally constrained inhibitors of caspase-1 (interleukin-1β converting enzyme) and of the human ced-3 homologue caspase-3 (CPP32, apopain)

Bioorganic & medicinal chemistry letters, 1998-10, Vol.8 (19), p.2757-2762

1998

Volltextzugriff (PDF)

Vasopeptidase Inhibitors: Incorporation of Geminal and Spirocyclic Substituted Azepinones in Mercaptoacyl Dipeptides

Journal of medicinal chemistry, 1999-01, Vol.42 (2), p.305-311

1999

Volltextzugriff (PDF)

Activation of the CED3/ICE-Related Protease CPP32 in Cerebellar Granule Neurons Undergoing Apoptosis But Not Necrosis

The Journal of neuroscience, 1997-01, Vol.17 (2), p.553-562

1997

Volltextzugriff (PDF)

Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors

The Journal of biological chemistry, 1996-07, Vol.271 (28), p.16850-16855

1996

Volltextzugriff (PDF)

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

Journal of medicinal chemistry, 1988-06, Vol.31 (6), p.1148-1160

1988

Volltextzugriff (PDF)

Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids: A New Class of Dual PPARα/γ Agonists

Journal of medicinal chemistry, 2001-06, Vol.44 (13), p.2061-2064

2001

Volltextzugriff (PDF)

Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury

The Journal of pharmacology and experimental therapeutics, 2001-05, Vol.297 (2), p.811

2001

Volltextzugriff (PDF)

Activation of Membrane-Associated Procaspase-3 Is Regulated by Bcl-2

The Journal of cell biology, 1999-03, Vol.144 (5), p.915-926

1999

Volltextzugriff (PDF)

Synthetic studies on polyether antibiotics. 6. Total synthesis of monensin. 3. Stereocontrolled total synthesis of monensin

Journal of the American Chemical Society, 1979-01, Vol.101 (1), p.262-263

1979

Volltextzugriff (PDF)

A highly selective protocol for the deprotection of BOC-protected amides and carbamates

Tetrahedron letters, 1993-12, Vol.34 (49), p.7873-7876

1993

Volltextzugriff (PDF)

Synthetic transformations of the mevinic acid nucleus: Preparation of a monocyclic analogue of compactin

Tetrahedron letters, 1991-08, Vol.32 (32), p.3911-3914

Karanewsky, Donald S.

1991

Volltextzugriff (PDF)

New conditions for controlled Claisen rearrangements of allyl aryl ethers

Journal of organic chemistry, 1976-09, Vol.41 (18), p.3026-3027

1976

Volltextzugriff (PDF)

An efficient and mild synthesis of highly substituted imidazoles

Tetrahedron letters, 1994-03, Vol.35 (11), p.1635-1638

1994

Volltextzugriff (PDF)

Practical synthesis of an enantiomerically pure synthon for the preparation of mevinic acid analogs

Journal of organic chemistry, 1991-05, Vol.56 (11), p.3744-3747

1991

Volltextzugriff (PDF)

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE

Journal of medicinal chemistry, 1988-01, Vol.31 (1), p.204-212

1988

Volltextzugriff (PDF)

Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: Heterocyclic P3

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (7), p.1975-1980

2006

Volltextzugriff (PDF)

Synthesis of phosphonic monoesters from phosphonous acids

Tetrahedron letters, 1986, Vol.27 (16), p.1751-1754

1986

Volltextzugriff (PDF)

Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety

Journal of medicinal chemistry, 1991-09, Vol.34 (9), p.2804-2815

1991

Volltextzugriff (PDF)

Structure–activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor α/β agonist scaffold

Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (5), p.1463-1466

2005

Volltextzugriff (PDF)

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogs of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline

Journal of medicinal chemistry, 1990-05, Vol.33 (5), p.1459-1469

1990

Volltextzugriff (PDF)

Rational Design and Biochemical Utility of Specific Inhibitors of Angiotensin-Converting Enzyme

Journal of cardiovascular pharmacology, 1987, Vol.10 Suppl 7, p.17-30

1987

Volltextzugriff (PDF)

Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids

Journal of medicinal chemistry, 2003-09, Vol.46 (19), p.4087-4103

2003

Volltextzugriff (PDF)

Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activity

Arzneimittel-Forschung, 1986-12, Vol.36 (12), p.1787

1986

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Novel (2E,4E,6Z)-7-(2-Alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic Acid Retinoid X Receptor Modulators Are Active in Models of Type 2 Diabetes

Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone

Conformationally constrained inhibitors of caspase-1 (interleukin-1β converting enzyme) and of the human ced-3 homologue caspase-3 (CPP32, apopain)

Vasopeptidase Inhibitors: Incorporation of Geminal and Spirocyclic Substituted Azepinones in Mercaptoacyl Dipeptides

Activation of the CED3/ICE-Related Protease CPP32 in Cerebellar Granule Neurons Undergoing Apoptosis But Not Necrosis

Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

Design and Synthesis of 2-Methyl-2-{4-[2-(5-methyl-2-aryloxazol- 4-yl)ethoxy]phenoxy}propionic Acids: A New Class of Dual PPARα/γ Agonists

Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury

Activation of Membrane-Associated Procaspase-3 Is Regulated by Bcl-2

Synthetic studies on polyether antibiotics. 6. Total synthesis of monensin. 3. Stereocontrolled total synthesis of monensin

A highly selective protocol for the deprotection of BOC-protected amides and carbamates

Synthetic transformations of the mevinic acid nucleus: Preparation of a monocyclic analogue of compactin

New conditions for controlled Claisen rearrangements of allyl aryl ethers

An efficient and mild synthesis of highly substituted imidazoles

Practical synthesis of an enantiomerically pure synthon for the preparation of mevinic acid analogs

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE

Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: Heterocyclic P3

Synthesis of phosphonic monoesters from phosphonous acids

Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety

Structure–activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor α/β agonist scaffold

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogs of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline

Rational Design and Biochemical Utility of Specific Inhibitors of Angiotensin-Converting Enzyme

Design, Synthesis, and Structure−Activity Relationship Studies of Novel 6,7-Locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic Acids

Suchergebnisse filtern